Vimarsana
Biggest News Aggregation in the World

Marketing Authorization News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marketing Authorization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marketing Authorization Today - Breaking & Trending Today

PTC Therapeutics Announces Validation of Sepiapterin European MAA - Vimarsana News

PTC Therapeutics Announces Validation of Sepiapterin European MAA

- Review of European marketing application for PKU now initiated - WARREN, N.J., May 28, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. announced today that the sepiapterin MAA for PKU has been...

Gilead Sciences, Inc.: Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024 - Vimarsana News

Gilead Sciences, Inc.: Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024

Key Findings from PBC, HDV, HCV, HBV and MASH/Fibrosis Studies Affirm Commitment to Drive Life-changing Science in Liver Disease - Gilead Sciences, Inc. (Nasdaq:GILD) today announced new research

Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs - Vimarsana News

Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs

– Total revenues of $881 million in the first quarter – Jakafi® net product revenues of $572 million in Q1'24, total paid patients increased +5% Y/Y; reiterating full year 2024 guidance of...

CJEU: Foreign patent invalidity defence in cross-border case - Attorney General Emiliou Delivers Opinion in BSH Hausgeräte v Electrolux Case (Case C‑339/22) | Hogan Lovells - Vimarsana News

CJEU: Foreign patent invalidity defence in cross-border case - Attorney General Emiliou Delivers Opinion in BSH Hausgeräte v Electrolux Case (Case C‑339/22) | Hogan Lovells

On 22 February 2024, Attorney-General (AG) Emiliou delivered an opinion in the BSH Hausgeräte/Electrolux case (C‑339/22). The opinion deals with the interpretation of Article 24(4) of...

4SC: Landmark RESMAIN study data presented at the 5th World Congress of Cutaneous Lymphomas - Vimarsana News

4SC: Landmark RESMAIN study data presented at the 5th World Congress of Cutaneous Lymphomas

Resminostat (Kinselby) as a maintenance therapy is now clinically proven to postpone disease progression in advanced Cutaneous T-Cell Lymphoma (CTCL) which could significantly change current clinical practice.Planegg-Martinsried, Germany, 11 April 2024 – 4SC AG (4SC, FSE Prime Standard: VSC), a biotech company...